Author: Pat Monarch

Prestigious Doctor Calls Neglect of Virus Drug Effectiveness Criminal

Posted by Pat Monarch | Mar 11, 2020 | Health, Market News, Pharmaceutical

“It’s really a crime to see something that’s this effective not being mentioned in more detail” – Dr. Bruce Patterson. Picture courtessy of Smithsonian Magazine

Read More

CytoDyn’s Vyralogix to fight COVID-19 – Hoping to treat Phase 2 and 3 Covid-19 Patients

Posted by Pat Monarch | Mar 9, 2020 | Markets, Pharmaceutical, Public Companies

Conference Call for Updates on Filing Phase 2 Trial with FDA for Treatment of Coronavirus in U.S., Status of BLA, Breakthrough Therapy Designation, Basket Trial for 22 Solid Tumor Cancers and Licensing Opportunities in Several Countries

Read More

Write for MN1.com

Latest Videos

Latest Articles

CanaFarma Hemp Products Corp. Signs Joint Venture Agreement with Jonathan Cheban’s Brand, Foodgod
Jul 29, 2020 | Canafarma, Cannabis, Entertainment, Food Service Industry, Health, Hemp, Legal, Market News, Markets
CanaFarma ‘Kirill Chumenko’ Now Serves as Senior Vice President
Jul 28, 2020 | Canafarma, Cannabis, Health, Hemp, Market News, Markets, Public Companies
Deepen Your Sleep With Melatonin Hemp-Infused Gum
Jul 27, 2020 | Canafarma, Cannabis, Health, Hemp, Market News, Markets, Public Companies, Retail
Season Executive Frank Barone Helps Lead Rising Company CanaFarma as Company’s Chief Operating Officer
Jul 21, 2020 | Canafarma, Cannabis, Health, Hemp, Market News, Markets, Media, Public Companies, Retail, Trading
The New Tasty Morning Gum That Boosts Energy and Focus
Jul 20, 2020 | Canafarma, Cannabis, Food Service Industry, Health, Hemp, Market News, Markets, Public Companies
CANAFARMA HEMP PRODUCTS CORP. SIGNS EXCLUSIVE EUROPEAN FULFILLMENT AND PRODUCTION AGREEMENT
Jul 16, 2020 | Canafarma, Cannabis, Health, Hemp, Market News, Markets, Pharmaceutical, Public Companies